Seranti Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Secunderabad, Telangana, India, established in 2010.
2010 Secunderabad, Telangana, India Active
Last Updated:
Access Report
About Seranti Pharmaceuticals Private Limited

Seranti Pharmaceuticals Private Limited, a active private limited company, was established on 04 November 2010 in Secunderabad, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24233TG2010PTC071088. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.16 M.

It upholds a compliant status. Its leadership includes Ahuti Rautaray (Managing Director), Susanta Senapati (Director). Past directors included Minati Senapati. It holds ₹4.72 M open charges and ₹1.85 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, 500010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2010PTC071088

  • Registration Number

    071088

  • Incorporation Date

    04 November 2010

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.16 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.16 M
  • Company Age 15 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.72 M
  • Satisfied Charges ₹ 1.85 M
  • Revenue Growth **** 12.32%
  • Profit Growth **** 3.23%
  • Ebitda **** 0.47%
  • Net Worth 4.77%
  • Total Assets **** 3.93%
Company report

Seranti Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Seranti Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Seranti Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ahuti Rautaray Managing Director 04 Nov 2010 Current
Susanta Senapati Director 14 Dec 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Seranti Pharmaceuticals.

Seranti Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.32% increase. The company also saw a slight improvement in profitability, with a 3.23% increase in profit. The company's net worth moved up by a moderate rise of 4.77%.

Seranti Pharmaceuticals revenue growth over time
Seranti Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.32%
*******
*******
*******
*******
Revenue from Operations
*******
 12.36%
*******
*******
*******
*******
Total Assets
*******
 3.93%
*******
*******
*******
*******
Profit or Loss
*******
 3.23%
*******
*******
*******
*******
Net Worth
*******
 4.77%
*******
*******
*******
*******
EBITDA
*******
 0.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Seranti Pharmaceuticals?

Unlock access to Seranti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,720,000.00

Satisfied Charges

₹1,850,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.47 Cr
Latest Charge Details
Date Lender Amount Status
30 Apr 2022 Others ₹0.24 M Open
30 Apr 2022 Others ₹0.48 M Open
31 May 2016 Others ₹4.00 M Open
20 Aug 2014 Syndicate Bank ₹1.35 M Satisfied
05 Dec 2013 Oriental Bank Of Commerce ₹0.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Seranti Pharmaceuticals?

Seranti Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Seranti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seranti Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Seranti Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Seranti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Seranti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge with Others of Rs. 4.00 M registered on 31 May 2016 with Charge ID 100038369 was modified on 24 Jun 2023. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.24 M with Charge ID 100569552 was registered on 30 Apr 2022. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.48 M with Charge ID 100569553 was registered on 30 Apr 2022. was documented.

  • Director Appointment

    Progress on Susanta Senapati was appointed as a Director was appointed as a Director on 14 Dec 2020 & has been associated with this company since 5 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Seranti Pharmaceuticals Private Limited?

The CIN of Seranti Pharmaceuticals Private Limited is U24233TG2010PTC071088.

Where is Seranti Pharmaceuticals Private Limited headquartered?

Seranti Pharmaceuticals Private Limited is headquartered at 3-3-66/Fc Surya Selter-I, Infront Of Bolaram Stati Risala Bazar Burtonguda, Secunderabad, Telangana, 500010.

When was Seranti Pharmaceuticals Private Limited incorporated?

Seranti Pharmaceuticals Private Limited was incorporated on 04 November 2010.

Who are the current directors of Seranti Pharmaceuticals Private Limited?

The current directors of Seranti Pharmaceuticals Private Limited are

What is the primary industry of Seranti Pharmaceuticals Private Limited?

The primary industry of Seranti Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Seranti Pharmaceuticals Private Limited a listed company?

Seranti Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Seranti Pharmaceuticals Private Limited?

The authorized capital of Seranti Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.16 M.

What is the compliance status of Seranti Pharmaceuticals Private Limited?

The compliance status of Seranti Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available